FDA OKs Talquetamab, a First-in-Class Multiple Myeloma Drug
The approval follows a series of market withdrawals for other multiple myeloma drugs that initially received accelerated FDA approval.
Stay updated with breaking news from Nt Ears. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The approval follows a series of market withdrawals for other multiple myeloma drugs that initially received accelerated FDA approval.
Patients with AF sometimes experience cognitive dysfunction after ablation. New data show it's short-lived and that ablation might in fact improve cognition in the long run.
Those who snore can be aging their brains by years and hurting their brain health by depriving themselves of getting deep sleep.
Two nonantibiotic strategies are moving forward as possible options for the most difficult NTM pathogens.
Ongoing wildfires in Canada pose a wide range of health risks for those exposed to the smoke.